Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

Goldman Sachs Reportedly Mulling Apple Card Move To Amex
Goldman Sachs Reportedly Mulling Apple Card Move To Amex

The Goldman Sachs Group (NYSE: GS) is reportedly in talks with American Express Co. (NYSE: AXP) regarding its Apple Inc. (NASDAQ: AAPL) credit card and other consumer-focused products connected

Dr. Reuter Investor Relations - Anlageklasse Wasser: Fünf Aktien, die Anleger auf dem Radar haben sollten
Dr. Reuter Investor Relations - Anlageklasse Wasser: Fünf Aktien, die Anleger auf dem Radar haben sollten

Wasser ist die essenzielle Ressource allen Lebens und ein kostbares Wirtschaftsgut. Zu kostbar, um es zu verschwenden. Der Markt für eine nachhaltige und effiziente Wasserwirtschaft ist

Eilt: Erstklassige Studienergebnisse im Kampf gegen Hautkrebs. Neuer 217% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB). Jetzt 217% mit Biotech Aktientip Vidac
Eilt: Erstklassige Studienergebnisse im Kampf gegen Hautkrebs. Neuer 217% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB). Jetzt 217% mit Biotech Aktientip Vidac

Eilt: Erstklassige Studienergebnisse im Kampf gegen Hautkrebs. Neuer 217% Biotech Hot Stock nach 134.452% mit Biogen

 

05.07.23 08:17

AC Research

 

London (www.aktiencheck.de, Anzeige)

 

 

Eilt: Sensationelle Studienergebnisse - Massives Kaufsignal. Neuer 224% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Eilt: Sensationelle Studienergebnisse - Massives Kaufsignal. Neuer 224% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)

Eilt: Sensationelle Studienergebnisse - Massives Kaufsignal. Neuer 224% Biotech Aktientip nach 31.205% mit Amgen ($AMGN)

 

04.07.23

AC Research

 

London (www.aktiencheck.de, Anzeige)

 

 

Tesla Production Cranks Into High Gear, Shares Follow
Tesla Production Cranks Into High Gear, Shares Follow

Tesla (NASDAQ: TSLA) was expected to increase production and set a record, but the Q2 results were shocking. The company produced 479,700 vehicles in the quarter and delivered 466,140 compared to

Ford Soars 30% YTD After Breaking Out: What's Next?
Ford Soars 30% YTD After Breaking Out: What's Next?

The renowned American automaker Ford Motor Company (NYSE: F)has been making significant progress in the market this year, with its stock up over 30% YTD. Shares of Ford recently broke out of a

Pure Storage is Pure Gold for Customers and Investors
Pure Storage is Pure Gold for Customers and Investors

Enterprise data storage solutions provider Pure Storage Inc. (NYSE: PSTG) stock has traded in a weekly rectangle trading range for over a year as shares attempt another breakout at the upper

Tesla: Can Downgrades Make Sense After A 170% Rally?
Tesla: Can Downgrades Make Sense After A 170% Rally?

Sometimes the stock market can really make you scratch your head. As investors, we’re used to being always told to follow a trend, buy into a good thing, don’t catch the falling knife. This is why

Buffett's Berkshire Increases Stake In Occidental Petroleum (OXY)
Buffett's Berkshire Increases Stake In Occidental Petroleum (OXY)

Warren Buffett's Berkshire Hathaway (NYSE: BRK.A) (NYSE: BRK.B) disclosed in a filing late Wednesday that it purchased an additional 2,138,250 shares of Occidental Petroleum (NYSE: OXY). Buffett's

Rally Gains Momentum On Soft PCE Data
Rally Gains Momentum On Soft PCE Data

The S&P 500 (NYSE: SPY) extended its summer rally after softer-than-expected PCE price data. The data is the latest in a string of good news that will help lift the market into mid-summer. The

Bank of America, JPMorgan, Goldman Sachs Set For Dividend Growth?
SMART Global Holdings Momentum, Room To Move Higher?
SMART Global Holdings Momentum, Room To Move Higher?

SMART Global Holdings (NASDAQ: SGH) is part of the semiconductor family, a sector that has taken on the spotlight during the past few weeks; the attention to the space was drawn after NVIDIA

Freeport-McMoRan: Analysts Bullish Ahead Of Growth Copper's Spurt
Freeport-McMoRan: Analysts Bullish Ahead Of Growth Copper's Spurt

When you think of the metal most crucial to the rapidly growing movement toward decarbonization, lithium might pop into your mind, as its use in batteries has been widely touted. 

But copper is

The Nike Rebound Is Over; Buying Opportunity Ahead
The Nike Rebound Is Over; Buying Opportunity Ahead

Nike (NYSE: NKE) proved again that it can Just Do It when operating in an ever-changing business environment. The Q3 results and guidance prove the company’s resiliency but also give evidence of

Verve Therapeutics Gains 20.74% In June as Ark Funds Invest
Verve Therapeutics Gains 20.74% In June as Ark Funds Invest

Small-cap biotech Verve Therapeutics Inc. (NASDAQ: VERV) is up 20.74% in June, with some of that gain due to Cathie Wood’s Ark funds adding shares. 

Verve, which was founded in 2018 and went

Is it Time To Ring The Register On Paychex?
Is it Time To Ring The Register On Paychex?

Paychex (NASDAQ: PAYX) shares are up more than 140% from the 2020 lows, but it may be time to ring the register. The Q4 results and outlook are good enough but failed to spark a rally in the

Micron Technology: A Reversal Is Imminent
Micron Technology: A Reversal Is Imminent

Micron Technologies (NASDAQ: MU) has been suffering through an inventory correction that has yet to run its course, but a reversal in share prices is imminent. The Q3 results, as bad as they were

McCormick Rebound Imminent: Executive Transition Complete
McCormick Rebound Imminent: Executive Transition Complete

McCormick's (NYSE: MKC) price action wobbled following a better-than-expected Q2 and increased guidance. The news proves that the decision to transition Brenden Foley into the CEO position was

Will Xponential Fitness Recover From a Short Seller Knockout?
Will Xponential Fitness Recover From a Short Seller Knockout?

Ding, ding, ding! A heated stock battle is underway with boutique gym franchisor Xponential Fitness, Inc. (NYSE: XPOF) at the center of the ring. 

In the red corner — bearish short selling firm

Rising AI & Falling Shares: Nvidia Facing New Export Restrictions
Rising AI & Falling Shares: Nvidia Facing New Export Restrictions

Nvidia Corp.’s (NASDAQ: NVDA) meteoric year-to-date increase of 186.60% is largely due to the company’s semiconductors that are behind the boom in artificial intelligence applications. 

But

Google Was Just Downgraded, But This Could Be A Good Thing
Google Was Just Downgraded, But This Could Be A Good Thing

After watching their shares rally by more than 50% from last November, it must have been a kick in the teeth for Alphabet Inc (NASDAQ: GOOGL), better known as Google, to receive two downgrades

Apple's Bull Run And Why It's Different
Apple's Bull Run And Why It's Different

A funny thing has been happening on Wall Street recently. Some of the biggest and brightest tech stocks have received cautious downgrades from analysts despite posting significant returns this

AMD's Recent Correction: A Buying Opportunity For Investors?
AMD's Recent Correction: A Buying Opportunity For Investors?

Advanced Micro Devices (NASDAQ: AMD) has been one of the standout performing semiconductor and NASDAQ companies of 2023. YTD shares of the semiconductor company are up about 70%, last trading near

Splunk Climbs 6% Since Earnings Report, May See New Buy Zone Soon
Splunk Climbs 6% Since Earnings Report, May See New Buy Zone Soon

Data analytics software developer Splunk Inc. (NASDAQ: SPLK) is up more than 6% since its most recent quarterly earnings report in May.  

Like many stocks, Splunk's recent price action has been